John P. Schmid
Director · BlossomHill Therapeutics, Inc.
- 2025
- Aug 10, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John P. Schmid files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $10.00M in BLSM purchases and sales in the last 12 months
- Carl L. Gordon - $10.00M in BLSM purchases and sales in the last 12 months
- Bihua Chen - $5.00M in BLSM purchases and sales in the last 12 months
- Vincent Paul Liptak - $75K in BLSM purchases and sales in the last 12 months
- Jason A. Keyes - $11K in BLSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John P. Schmid?
John P. Schmid is a corporate insider, tracked as Director of BlossomHill Therapeutics, Inc. (BLSM). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John P. Schmid submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John P. Schmid been buying or selling stock?
Recorded transactions: 1 open-market purchase ($96K) and 3 open-market sales ($1.16M) across all tracked filings.
